Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03121950 · ClinicalTrials.gov registry record · NA

Movement and Music Intervention for Individuals With Dementia

A NA study, sponsored by Ohio State University.

Completed
Registry status
NA
Development phase
21
Enrollment target

NCT03121950: Completed NA study, sponsored by Ohio State University.

NCT03121950 is a NA study that has completed, run by Ohio State University. The registered enrollment target is 21 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03121950, a NA study, has completed, sponsored by Ohio State University.

COMPLETED
Registry status
NA
Development phase
21 participants
Enrollment target

Study Summary

The goal of the study is to learn about how possible benefits of movement and music for individuals with dementia. Individuals with dementia will participate in a dance class. The study includes assessments of walking, balance and cognition.

Primary Outcome

The change in time to complete the Timed Up and Go - Cognitive (TUG-Cog) is recorded in seconds. The participant is timed with a stop watch while walking 3 meters turning and returning to a chair while performing a concurrent cognitive task. This time is compared to the Timed Up and Go (TUG) and the difference in time indicates the effect cognitive deficits have on motor function. Higher scores, indicating more time, means worse outcomes.

Interventions

  • OTHER Music
  • OTHER Dance

Trial Details

FieldValue
Enrollment Target 21 participants
Start Date 2017-04-01
Est. Completion 2017-12-30
Phase NA
Ohio State University

552 total trials

What the finished NCT03121950 record still lists

NCT03121950 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 21 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 2 interventions - of which Music is the first listed.

NCT03121950 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03121950 about?

NCT03121950 is a clinical study titled "Movement and Music Intervention for Individuals With Dementia". The goal of the study is to learn about how possible benefits of movement and music for individuals with dementia. Individuals with dementia will participate in a dance class. The study includes assessments of walking, balance and cognition.

What is the current status of trial NCT03121950?

This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2017-04-01. Estimated completion is 2017-12-30.

What interventions are being tested in trial NCT03121950?

The interventions under investigation include: Music (OTHER), Dance (OTHER).

Who is sponsoring clinical trial NCT03121950?

This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03121950's enrollment target sits among peer trials

21 1762nd of 2000 higher than 233 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02447874 · 21 participants · Phase 1

    Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease

  • NCT03826992 · 21 participants · Phase 1

    Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia

  • NCT04107077 · 21 participants · Phase 2

    Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer

  • NCT04158635 · 21 participants · Phase 1

    Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03121950, the US trial registry maintained by the National Library of Medicine. NCT03121950 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.